Cyxone investor relations material

Listen to the latest call from Cyxone

Cyxone AB (publ) is a clinical biotech company focusing on the development of new therapies to treat autoimmune diseases and acute respiratory disorders. The company's lead products include Cyxonexim (rheumatoid arthritis), and Cyxonidexim (multiple sclerosis).

Dig deeper into the Cyxone fundamentals on Quartr.